Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00086671
Recruitment Status : Completed
First Posted : July 9, 2004
Last Update Posted : January 4, 2013
Sponsor:
Information provided by (Responsible Party):
AbbVie ( AbbVie (prior sponsor, Abbott) )

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 2006
  Actual Study Completion Date : November 2006
  Certification/Extension First Submitted : August 24, 2011